BCL2A1 and melanoma: However, studies have also shown that Bfl-1 mRNA levels are relatively high in melanoma compared to other tumors23,25, and reducing BFL-1 levels by siRNA increases spontaneous cell killing and ABT-737 sensitivity, though this effect was small (~2-fold)17,19,23.